Skip to main content

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1‐PDGFRA‐Associated Myeloid Neoplasm With Eosinophilia

Publication ,  Journal Article
Jain, J; Weinzierl, EP; Saxe, D; Bergsagel, J; Gotlib, J; Reiter, A; Raikar, SS
Published in: HemaSphere
December 2020

Duke Scholars

Published In

HemaSphere

DOI

EISSN

2572-9241

ISSN

2572-9241

Publication Date

December 2020

Volume

4

Issue

6

Publisher

Wiley
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jain, J., Weinzierl, E. P., Saxe, D., Bergsagel, J., Gotlib, J., Reiter, A., & Raikar, S. S. (2020). Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1‐PDGFRA‐Associated Myeloid Neoplasm With Eosinophilia. HemaSphere, 4(6). https://doi.org/10.1097/hs9.0000000000000486
Jain, Juhi, Elizabeth P. Weinzierl, Debra Saxe, John Bergsagel, Jason Gotlib, Andreas Reiter, and Sunil S. Raikar. “Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1‐PDGFRA‐Associated Myeloid Neoplasm With Eosinophilia.” HemaSphere 4, no. 6 (December 2020). https://doi.org/10.1097/hs9.0000000000000486.
Jain, Juhi, et al. “Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1‐PDGFRA‐Associated Myeloid Neoplasm With Eosinophilia.” HemaSphere, vol. 4, no. 6, Wiley, Dec. 2020. Crossref, doi:10.1097/hs9.0000000000000486.

Published In

HemaSphere

DOI

EISSN

2572-9241

ISSN

2572-9241

Publication Date

December 2020

Volume

4

Issue

6

Publisher

Wiley